SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter ...

Over-the-counter continuous glucose monitors have moved from a diabetes-only tool into the broader metabolic health conversation, and shoppers now face a real decision. Here is an OTC CGM comparison ...

FDA clears Dexcom Stelo as the first OTC CGM for children, raising new questions around app access, caregiver oversight, school device rules, and reimbursement.

Following expanded FDA approval for pediatric patients, the over-the-counter Stelo continuous glucose monitor is adding AI coaching and other app-based features.

Parents of young children with elevated blood sugar now have a new option that does not require a doctor’s prescription. The ...

Add Yahoo as a preferred source to see more of our stories on Google. The US Food and Drug Administration has approved Dexcom's Stelo Glucose Biosensor System, the first over-the-counter continuous ...

Wearable glucose trackers have moved from the pharmacy counter to the checkout aisle, and the OTC CGM comparison shoppers are now making at home looks a lot like the one diabetes patients used to ...

Add Yahoo as a preferred source to see more of our stories on Google. The US Food and Drug Administration (FDA) has cleared Dexcom's Stelo glucose biosensor system for children, making it the first ...

This popular CGM can now be marketed for children 2 years of age and older who do not use insulin. Anna Gragert Senior Editor, Health and Home Anna Gragert (she/her/hers) was previously the lifestyle ...

The U.S. Food and Drug Administration (FDA) has cleared the first over-the-counter wearable device to track blood sugar in young children. The continuous glucose monitor (CGM)—called the Stelo Glucose ...